Search trials



Primary RegistryProtocol numberPublic titleScientific titleType of studyRecruitment statusLast updated
LBCTR2020093402IMR-BTL-201A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta ThalassemiaA Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta ThalassemiaInterventionalPending24/02/2020
LBCTR2020083421IMR-SCD-301A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell DiseaseA Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell DiseaseInterventionalPending26/08/2020
LBCTR2020043428APD334-303An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisAn Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative ColitisInterventionalPending01/12/2020
LBCTR2020043459HDF 1632The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online surveyThe effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey ObservationalPending16/04/2020
LBCTR2020063508WIL-31 CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF WILATE DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD) CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF WILATE DURING PROPHYLAXIS IN PREVIOUSLY TREATED PATIENTS WITH VON WILLEBRAND DISEASE (VWD)InterventionalPending09/06/2020
LBCTR2021024523GC1801Phase 3 study to evaluate the efficacy and safety of human plasma-derived fibrinogen concentrate (FIB Grifols) in subjects with congenital afibrinogenaemia and severe hypofibrinogenemiaA prospective, multicenter, open-label, single-arm study to evaluate the efficacy and safety of human plasma-derived fibrinogen concentrate (FIB Grifols) in subjects with congenital afibrinogenaemia and severe hypofibrinogenemia requiring either ondemand treatment for acute bleeding or surgical prophylaxisInterventionalPending14/07/2020
LBCTR2020094566FGCL-3019-095Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)InterventionalPending01/03/2021
LBCTR2020104612BIO-2019-0257Impact of Phosphorus Ingestion with Fructose and Glucose on Substrate Utilization in Active Individuals During Moderate Exercise Impact of Phosphorus Ingestion with Fructose and Glucose on Substrate Utilization in Active Individuals During Moderate Exercise InterventionalPending08/10/2020
LBCTR2021014651000000Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical Trial at the Lebanese American University Medical Center- Rizk HospitalManaging Endothelial Dysfunction in COVID-19: A Randomized Clinical Trial at the Lebanese American University Medical Center- Rizk HospitalInterventionalPending07/02/2021
LBCTR2020043495Solidarity-Lebanon2020An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careAn international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careInterventionalPending22/04/2020
items per page91 - 100 of 169 items